Role of Mas receptor in renal blood flow response to angiotensin-(1-7) in ovariectomized estradiol treated rats

Shadan Saberi, Aghdas Dehghani, Mehdi Nematbakhsh


The angiotensin 1-7 (Ang 1-7), is abundantly produced in kidneys and antagonizes the function of angiotensin II through Mas receptor (MasR) or other unknown mechanisms. In the current study, the role of MasR and steroid hormone estrogen on renal blood flow response to Ang 1-7 administration was investigated in ovariectomized (OV) female rats. OV female Wistar-rats received estradiol (500 µg/kg/week) or vehicle for two weeks. In the day of the experiment, the animals were anesthetized, cannulated, and the responses including mean arterial pressure, renal blood flow (RBF), and renal vascular resistance at the constant level of renal perfusion pressure to graded infusion of Ang 1-7 at 0, 100 and 300 ng/kg/min were determined in OV and OV estradiol-treated (OVE) rats, treated with vehicle or MasR antagonist; A779. RBF response to Ang 1-7 infusion increased dose-dependently in vehicle (Pdose<0.001) and A779-treated (Pdose<0.01) animals. However, when MasR was blocked, the RBF response to Ang 1-7 significantly increased in OV animals compared with OVE rats (P<0.05). When estradiol was limited by ovariectomy, A779 increased RBF response to Ang 1-7 administration, while this response was attenuated in OVE animals.

Full Text:



Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1–7) by angiotensin-converting enzyme. Hypertension. 1998;31:362-367.

Santos RA, Ferreira AJ, e Silva ACS. Recent advances in the angiotensin-converting enzyme 2–angiotensin (1–7)–Mas axis. Exp Physiol. 2008;93:519-527.

Ferreira AJ, Santos RA, Bradford CN, Mecca AP, Sumners C, Katovich MJ, et al. Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension. 2010;55:207-213.

Iwai M, Horiuchi M. Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis. Hypertension Res. 2009;32:533-536.

Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol. 1995;269:H313-H319.

Ren Y, Garvin JL, Carretero OA. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension. 2002;39:799-802.

Sampaio WO, Nascimento AA, Santos RA. Systemic and regional hemodynamic effects of angiotensin-(1–7) in rats. Am J Physiol-Heart Circ Physiol. 2003;284:H1985-H1994.

Nematbakhsh M, Safari T. Role of Mas receptor in renal blood flow response to angiotensin (1-7) in male and female rats. Gen Physiol Biophys. 2014;33:365-372.

Mansoori A, Oryan S, Nematbakhsh M. Role of Mas receptor antagonist (A779) on pressure diuresis and natriuresis and renal blood flow in the absence of angiotensin II receptors type 1 and 2 in female and male rats. J Physiol Pharmacol. 2014;65:633-639.

Chidambaram M, Duncan JA, Lai VS, Cattran DC, Floras JS, Scholey JW, et al. Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol. 2002;13:446-452.

Sullivan JC, Bhatia K, Yamamoto T, Elmarakby AA. Angiotensin (1-7) Receptor antagonism equalizes angiotensin II–Induced hypertension in male and female spontaneously hypertensive rats. J Hypertension. 2010;56:658-666.

Brown RD, Hilliard LM, Head GA, Jones ES, Widdop RE, Denton KM. Sex differences in the pressor and tubuloglomerular feedback response to angiotensin II. Hypertension. 2012;59:129-135.

Merrill DC, Karoly M, Chen K, Ferrario CM, Brosnihan KB. Angiotensin-(1–7) in normal and preeclamptic pregnancy. Endocrine. 2002;18: 239-245.

Kang AK, Duncan JA, Cattran DC, Floras JS, Lai V, Scholey JW, et al. Effect of oral contraceptives on the renin angiotensin system and renal function. Am J Physiol Regul Integr Comp Physiol. 2001;280:R807-R813.

Safari T, Nematbakhsh M, Hilliard LM, Evans RG, Denton KM. Sex differences in the renal vascular response to angiotensin II involves the Mas receptor. Acta Physiol (Oxf). 2012;206:150-156.

Macova M, Armando I, Zhou J, Baiardi G, Tyurmin D, Larrayoz-Roldan IM, et al. Estrogen reduces aldosterone, upregulates adrenal angiotensin II AT2 receptors and normalizes adrenomedullary Fra-2 in ovariectomized rats. Neuroendocrinology. 2008;88:276-286.

Botelho-Santos GA, Sampaio WO, Reudelhuber TL, Bader M, Campagnole-Santos MJ, dos Santos RAS. Expression of an angiotensin-(1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance. Am J Physiol Heart Circul Physiol. 2007;292:H2485-H9240.

van der Wouden EA, Ochodnický P, van Dokkum RP, Roks AJ, Deelman LE, de Zeeuw D, et al. The role of angiotensin (1–7) in renal vasculature of the rat. Hypertension. 2006;24:1971-198.

Chappell M, Modrall J, Diz D, Ferrario C. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. Contrib Nephrol. 2004;143:77-89.

Costa AP, Fagundes-Moura CR, Pereira VM, Silva LF, Vieira MAR, Santos RA, et al. Angiotensin-(1–7): a novel peptide in the ovary. Endocrinol. 2003;144:1942-1948.

Liu J, Ji H, Zheng W, Wu X, Zhu JJ, Arnold AP, et al. Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17b-oestradioldependent and sex chromosome-independent. Biol Sex Differ. 2010;1:6.

Ji H, Menini S, Zheng W, Pesce C, Wu X, Sandberg K. Role of angiotensin-converting enzyme 2 and angiotensin (1–7) in 17β-oestradiol regulation of renal pathology in renal wrap hypertension in rats. Exp. Physiol. 2008;93:648-657.

Sampson AK, Hilliard LM, Moritz KM, Thomas MC, Tikellis C, Widdop RE, et al. The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent. Am J Physiol-Regul Integr Comp Physiol. 2012;302:R159-R165.

Schneider MP, Wach PF, Durley MK, Pollock JS, Pollock DM. Sex differences in acute ANG II-mediated hemodynamic responses in mice. Am J Physiol Regul Integr Comp Physiol. 2010;299:R899-R906.

Wang H, Jessup JA, Zhao Z, Da Silva J, Lin M, Mac Namara LM, et al. Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2. Lewis rats. PloS one. 2013;8:e76992.

Sobrino A, Novella S, Monsalve E, Oviedo P, Laguna-Fernandez A, Bueno C, et al. Estradiol regulates renin-angiotensin system towards nitric oxide production through mas receptor: Hypertension. 2010;28:e385.

Seely EW, Brosnihan KB, Jeunemaitre X, Okamura K, Williams GH, Hollenberg NK, et al. Effects of conjugated oestrogen and droloxifene on the renin–angiotensin system, blood pressure and renal blood flow in postmenopausal women. Clin Endocrinol. 2004;60:315-321.

Volterrani M, Rosano G, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med. 1995;99:119-122.

Magness RR, Phernetton TM, Zheng J. Systemic and uterine blood flow distribution during prolonged infusion of 17β-estradiol. Am J Physiol-Heart Circul Physiol. 1998;275:H731-H743.

Veille J-C, Li P, Eisenach JC, Massmann AG, Figueroa JP. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am J Obstet Gynecol. 1996;174:1043-1049.

Neves LA, Averill DB, Ferrario CM, Aschner JL, Brosnihan KB. Vascular responses to angiotensin-(1–7) during the estrous cycle. Endocrine. 2004;24:161-165.

Neves LA, Williams AF, Averill DB, Ferrario CM, Walkup MP, Brosnihan KB. Pregnancy enhances the angiotensin (Ang)-(1–7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1–7). Endocrinology. 2003;144:3338-3343.

Chappell MC, Diz DI, Yunis C, Ferrario CM. Differential actions of angiotensin-(1-7) in the kidney. Kidney Int Suppl. 1998;54:S3-S6.

Fernandes L, Fortes ZB, Nigro D, Tostes RC, Santos RA, de Carvalho MHC. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Hypertens. 2001;37:703-709.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.